Advanced search
Publication Cover
Dialogues in Clinical Neuroscience Volume 12, 2010 - Issue 3
Submit an article Journal homepage
1,690
Views
56
CrossRef citations to date
0
Altmetric
Pharmacological Aspects

Beyond the dopamine receptor: novel therapeutic targets for treating schizophrenia

Más allá del receptor de dopamina: nuevos blancos terapéuticos para tratar la esquizofrenia

Au-delà du récepteur dopaminergique: de nouvelles cibles thérapeutiques pour traiter la schizophrénie.

Joseph T. CoyleDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USACorrespondence[email protected]
,
Darrick BaluDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
,
Michael BenneyworthDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
,
Alo BasuDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
&
Alexander RosemanDepartment of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
Pages 359-382 | Published online: 01 Apr 2022

Citations (56)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Stefania Ruiu, Maria Antonietta Casu, Gianluca Casu, Sara Piras & Giorgio Marchese. (2012) Effects of controlled-release formulations of atypical antipsychotics on functioning and quality of life of schizophrenic individuals. Expert Opinion on Pharmacotherapy 13:11, pages 1631-1643.
Read now

Articles from other publishers (55)

Mallikarjuna Nimgampalle, Harshini Chakravarthy, Sapana Sharma, Shruti Shree, Anoop Ramachandra Bhat, Jangampalli Adi Pradeepkiran & Vasudharani Devanathan. (2023) Neurotransmitter systems in the etiology of major neurological disorders: Emerging insights and therapeutic implications. Ageing Research Reviews 89, pages 101994.
Crossref
Francesca McEwan, Jocelyn D. Glazier & Reinmar Hager. (2023) The impact of maternal immune activation on embryonic brain development. Frontiers in Neuroscience 17.
Crossref
Narasimha M. Beeraka, Marco F. Avila-Rodriguez & Gjumrakch Aliev. (2022) Recent Reports on Redox Stress-Induced Mitochondrial DNA Variations, Neuroglial Interactions, and NMDA Receptor System in Pathophysiology of Schizophrenia. Molecular Neurobiology 59:4, pages 2472-2496.
Crossref
Shunsuke Takagi, Matthew D. Puhl, Thea Anderson, Darrick T. Balu & Joseph T. Coyle. (2020) Serine Racemase Expression by Striatal Neurons. Cellular and Molecular Neurobiology 42:1, pages 279-289.
Crossref
Ju-Chun Pei, Da-Zhong Luo, Shiang-Shin Gau, Chia-Yuan Chang & Wen-Sung Lai. (2021) Directly and Indirectly Targeting the Glycine Modulatory Site to Modulate NMDA Receptor Function to Address Unmet Medical Needs of Patients With Schizophrenia. Frontiers in Psychiatry 12.
Crossref
Donald J. AbrahamSeth Ablordeppey & Edward Ofori. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery 1 69 .
Edmund T. Rolls. (2021) Attractor cortical neurodynamics, schizophrenia, and depression. Translational Psychiatry 11:1.
Crossref
Shunsuke Takagi, Darrick T. Balu & Joseph T. Coyle. (2021) Factors regulating serine racemase and d-amino acid oxidase expression in the mouse striatum. Brain Research 1751, pages 147202.
Crossref
Joelle Choueiry, Crystal M. Blais, Dhrasti Shah, Dylan Smith, Derek Fisher, Vadim Illivitsky & Verner Knott. (2020) CDP-choline and galantamine, a personalized α7 nicotinic acetylcholine receptor targeted treatment for the modulation of speech MMN indexed deviance detection in healthy volunteers: a pilot study. Psychopharmacology 237:12, pages 3665-3687.
Crossref
Dennis Kätzel, Amy R. Wolff, Alexei M. Bygrave & David M. Bannerman. (2020) Hippocampal Hyperactivity as a Druggable Circuit-Level Origin of Aberrant Salience in Schizophrenia. Frontiers in Pharmacology 11.
Crossref
Jean Claude Martel & Silvia Gatti McArthur. (2020) Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia. Frontiers in Pharmacology 11.
Crossref
Francesca Alemanno & Fernando Alemanno. 2020. Biochemistry for Anesthesiologists and Intensivists. Biochemistry for Anesthesiologists and Intensivists 123 138 .
Sara de la Salle, Dhrasti Shah, Joelle Choueiry, Hayley Bowers, Judy McIntosh, Vadim Ilivitsky & Verner Knott. (2019) NMDA Receptor Antagonist Effects on Speech-Related Mismatch Negativity and Its Underlying Oscillatory and Source Activity in Healthy Humans. Frontiers in Pharmacology 10.
Crossref
Michael C. Regan, Zongjian Zhu, Hongjie Yuan, Scott J. Myers, Dave S. Menaldino, Yesim A. Tahirovic, Dennis C. Liotta, Stephen F. Traynelis & Hiro Furukawa. (2019) Structural elements of a pH-sensitive inhibitor binding site in NMDA receptors. Nature Communications 10:1.
Crossref
Rachael Ingram, Heather Kang, Stafford Lightman, David E. Jane, Zuner A. Bortolotto, Graham L. Collingridge, David Lodge & Arturas Volianskis. (2018) Some distorted thoughts about ketamine as a psychedelic and a novel hypothesis based on NMDA receptor-mediated synaptic plasticity. Neuropharmacology 142, pages 30-40.
Crossref
Maria R Dauvermann, Graham Lee & Neil Dawson. (2017) Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research. British Journal of Pharmacology 174:19, pages 3136-3160.
Crossref
V.T. Ramaekers. 2017. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
V.T. Ramaekers, J.M. Sequeira & E.V. Quadros. (2016) The basis for folinic acid treatment in neuro-psychiatric disorders. Biochimie 126, pages 79-90.
Crossref
Robert E. Litman, Mark A. Smith, James J. Doherty, Alan Cross, Shane Raines, Lev Gertsik & Stephen R. Zukin. (2016) AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study. Schizophrenia Research 172:1-3, pages 152-157.
Crossref
Min-Yu SunYukitoshi Izumi, Ann BenzCharles F. Zorumski & Steven Mennerick. (2016) Endogenous 24 S -hydroxycholesterol modulates NMDAR-mediated function in hippocampal slices . Journal of Neurophysiology 115:3, pages 1263-1272.
Crossref
Joseph T. Coyle, Darrick T. Balu, Matthew D. Puhl & Glenn T. Konopaske. (2016) History of the Concept of Disconnectivity in Schizophrenia. Harvard Review of Psychiatry 24:2, pages 80-86.
Crossref
Mark Z. Kos, Melanie A. Carless, Juan Peralta, August Blackburn, Marcio Almeida, David Roalf, Michael F. Pogue-Geile, Konasale Prasad, Ruben C. Gur, Vishwajit Nimgaonkar, Joanne E. Curran, Ravi Duggirala, David C. Glahn, John Blangero, Raquel E. Gur & Laura Almasy. (2016) Exome Sequence Data From Multigenerational Families Implicate AMPA Receptor Trafficking in Neurocognitive Impairment and Schizophrenia Risk. Schizophrenia Bulletin 42:2, pages 288-300.
Crossref
D.T. Balu. 2016. Neuropsychopharmacology: A Tribute to Joseph T. Coyle. Neuropsychopharmacology: A Tribute to Joseph T. Coyle 351 382 .
A. Banerjee, K.E. Borgmann-Winter, R. Ray & C.-G. Hahn. 2016. The Neurobiology of Schizophrenia. The Neurobiology of Schizophrenia 125 147 .
Joseph T. Coyle. 2016. D-Amino Acids. D-Amino Acids 101 118 .
Germana Silva Vasconcelos, Naiara Coelho Ximenes, Caren Nádia Soares de Sousa, Tatiana de Queiroz Oliveira, Laio Ladislau Lopes Lima, David Freitas de Lucena, Clarissa Severino Gama, Danielle Macêdo & Silvânia Maria Mendes Vasconcelos. (2015) Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms. Schizophrenia Research 165:2-3, pages 163-170.
Crossref
Aranda R. Duan, Carmen Varela, Yuchun Zhang, Yinghua Shen, Lealia Xiong, Matthew A. Wilson & John Lisman. (2015) Delta Frequency Optogenetic Stimulation of the Thalamic Nucleus Reuniens Is Sufficient to Produce Working Memory Deficits: Relevance to Schizophrenia. Biological Psychiatry 77:12, pages 1098-1107.
Crossref
Jean-Francois Rousseau, Isaac Chekroun, Vincent Ferey & Jean Robert Labrosse. (2015) Concise Preparation of a Stable Cyclic Sulfamidate Intermediate in the Synthesis of a Enantiopure Chiral Active Diamine Derivative. Organic Process Research & Development 19:4, pages 506-513.
Crossref
Shunsuke Takagi, Darrick T. Balu & Joseph T. Coyle. (2015) Subchronic pharmacological and chronic genetic NMDA receptor hypofunction differentially regulate the Akt signaling pathway and Arc expression in juvenile and adult mice. Schizophrenia Research 162:1-3, pages 216-221.
Crossref
Kensuke Sakuma, Hidetoshi Komatsu, Minoru Maruyama, Sachiko Imaichi, Yugo Habata & Masaaki Mori. (2015) Temporal and Spatial Transcriptional Fingerprints by Antipsychotic or Propsychotic Drugs in Mouse Brain. PLOS ONE 10:2, pages e0118510.
Crossref
R. Bordet. (2015) Quels critères pour un traitement antipsychotique idéal ?. L'Encéphale 41:1, pages 39-46.
Crossref
Sylvain Dubroqua, Philipp Singer & Benjamin K. Yee. 2015. Psychiatry and Neuroscience Update. Psychiatry and Neuroscience Update 353 373 .
Jeffrey A. Vernon, Eugene Grudnikoff, Andrew J. Seidman, Thomas W. Frazier, Mani Sandhya Vemulapalli, Priyanki Pareek, Terry E. Goldberg, John M. Kane & Christoph U. Correll. (2014) Antidepressants for cognitive impairment in schizophrenia — A systematic review and meta-analysis. Schizophrenia Research 159:2-3, pages 385-394.
Crossref
Hyewon Shin & Jin-Ho Song. (2014) Antipsychotics, chlorpromazine and haloperidol inhibit voltage-gated proton currents in BV2 microglial cells. European Journal of Pharmacology 738, pages 256-262.
Crossref
Maria R. Dauvermann, Heather C. Whalley, André Schmidt, Graham L. Lee, Liana Romaniuk, Neil Roberts, Eve C. Johnstone, Stephen M. Lawrie & Thomas W. J. Moorhead. (2014) Computational Neuropsychiatry – Schizophrenia as a Cognitive Brain Network Disorder. Frontiers in Psychiatry 5.
Crossref
Ayelet Rosenthal-Simons, Andrea R. Durrant & Uriel Heresco-Levy. (2013) Autoimmune-induced glutamatergic receptor dysfunctions: Conceptual and psychiatric practice implications. European Neuropsychopharmacology 23:12, pages 1659-1671.
Crossref
Robert J. Harvey & Benjamin K. Yee. (2013) Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain. Nature Reviews Drug Discovery 12:11, pages 866-885.
Crossref
Benjamin K. Yee & Philipp Singer. (2013) A conceptual and practical guide to the behavioural evaluation of animal models of the symptomatology and therapy of schizophrenia. Cell and Tissue Research 354:1, pages 221-246.
Crossref
Maria R. Dauvermann, Heather C. Whalley, Liana Romaniuk, Vincent Valton, David G.C. Owens, Eve C. Johnstone, Stephen M. Lawrie & Thomas W.J. Moorhead. (2013) The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia. NeuroImage 73, pages 16-29.
Crossref
Peter J. Siekmeier & David P. vanMaanen. (2013) Development of Antipsychotic Medications with Novel Mechanisms of Action Based on Computational Modeling of Hippocampal Neuropathology. PLoS ONE 8:3, pages e58607.
Crossref
Chang-Hong Wang, Yan Li, Jun Yang, Lin-Yan Su, Yao-Guo Geng, Hao Li, Ji-Kang Wang & Jun-Lin Mu. (2013) A randomized controlled trial of olanzapine improving memory deficits in Han Chinese patients with first-episode schizophrenia. Schizophrenia Research 144:1-3, pages 129-135.
Crossref
Benjamin K. Yee, Philipp Singer & Detlev Boison. 2013. Adenosine. Adenosine 459 491 .
Francesco Errico, Francesco Napolitano, Robert Nisticò & Alessandro Usiello. (2012) New insights on the role of free d-aspartate in the mammalian brain. Amino Acids 43:5, pages 1861-1871.
Crossref
Michael A Benneyworth & Joseph T Coyle. (2012) Altered Acquisition and Extinction of Amphetamine-Paired Context Conditioning in Genetic Mouse Models of Altered NMDA Receptor Function. Neuropsychopharmacology 37:11, pages 2496-2504.
Crossref
J. T. Coyle. (2012) NMDA Receptor and Schizophrenia: A Brief History. Schizophrenia Bulletin 38:5, pages 920-926.
Crossref
Joseph T. Coyle. 2012. Translational Neuroscience. Translational Neuroscience 118 128 .
Darrick T. Balu & Donald C. Goff. 2012. Translational Neuroscience. Translational Neuroscience 80 106 .
Darrick T. Balu & Joseph T. Coyle. (2012) Neuronal d-serine regulates dendritic architecture in the somatosensory cortex. Neuroscience Letters 517:2, pages 77-81.
Crossref
Mendel Friedman & Carol E. Levin. (2011) Nutritional and medicinal aspects of d-amino acids. Amino Acids 42:5, pages 1553-1582.
Crossref
Edmund T. Rolls. (2012) Glutamate, obsessive–compulsive disorder, schizophrenia, and the stability of cortical attractor neuronal networks. Pharmacology Biochemistry and Behavior 100:4, pages 736-751.
Crossref
Joseph T. Coyle & Glenn T. Konopaske. 2012. Basic Neurochemistry. Basic Neurochemistry 1000 1011 .
Joseph T. Coyle, Alo Basu, Michael Benneyworth, Darrick Balu & Glenn Konopaske. 2012. Novel Antischizophrenia Treatments. Novel Antischizophrenia Treatments 267 295 .
A Carlo Altamura. (2011) From ‘classical’ antipsychotics to ‘multidimensional stabilizers’: do we need a new classification for novel drugs used in schizophrenia?. Neuropsychiatry 1:6, pages 541-552.
Crossref
Alkomiet Hasan, Thomas Wobrock, Daniela Reich-Erkelenz & Peter Falkai. (2011) Treatment of first-episode schizophrenia: pharmacological and neurobiological aspects. Drug Discovery Today: Therapeutic Strategies 8:1-2, pages 31-35.
Crossref
Jonathan Prousky, Christine G. Millman & James B. Kirkland. (2011) Pharmacologic Use of Niacin. Journal of Evidence-Based Complementary & Alternative Medicine 16:2, pages 91-101.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.